大麻使用障碍识别测试 - 消费 (CUDIT-C) 作为大麻使用查的有针对性的工具
Margy Y Chen1, Carillon J Skrzynski1, L Cinnamon Bidwell2
1Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, United States.
Addictive behaviors
|June 11, 2025
概括
大麻使用障碍识别测试 - 消费 (CUDIT-C) 有效地评估大麻使用,特别是在频繁使用者中,并显示出强大的THC水平的预测效用.
科学领域:
- 心理测量 心理测量 心理测量
- 大麻使用研究 大麻使用研究
- 药物使用障碍 药物使用障碍
背景情况:
- 大麻使用障碍识别测试 - 修订 (CUDIT-R) 是一个广泛使用的查工具.
- 一个更简短的版本,CUDIT-C,可能为评估大麻使用提供更有效的替代方案.
- 评估CUDIT-C的心理测量特性对于其临床应用至关重要.
研究的目的:
- 为了评估CUDIT-C.的心理测量特性.
- 为了评估与CUDIT-R.相比,CUDIT-C的预测效用.
- 检查CUDIT-C在不同程度的大麻消费者的有效性.
主要方法:
- 确认因素分析 (CFA) 用于测试CUDIT-R的双因素模型,其中CUDIT-C包括前两个项目.
- 参与者包括不经常 (N=108) 和频繁 (N=138) 的大麻使用者.
- 评估了CUDIT-C和CUDIT-R对预测自我报告的使用日和高峰血delta-9-tetrahydrocannabinol (THC) 水平的能力.
主要成果:
- 一个双因素模型提供了一个比一个单因素模型更好的合适.
- 在不经常使用者中,CUDIT-C的性能与CUDIT-R相似.
- 在频繁使用者中,CUDIT-C与CUDIT-R相匹配或表现优于CUDIT-R,特别是更有效地预测高峰THC水平.
结论:
- CUDIT-C是评估大麻使用的实用和有效工具,特别是在频繁使用者中.
- 它的实用性可能在不经常的用户中受到限制,因为其可变性有限.
- 建议对临床环境,多样化的群体和诊断大麻使用障碍进行进一步的研究.
更多相关视频
相关概念视频
Diagnostic and Statistical Manual of Mental Disorders (DSM)
48
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
48
Substance Use Disorders Affecting Sleep
161
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
161
Attention-Deficit/Hyperactivity Disorder
50
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
50
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
204
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
204


